Plasmid-Mediated Carbapenemase Genes in Enterobacter cloacae: Resistance Dynamics and Research Implications

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) pose a substantial challenge to global public health, with Enterobacter cloacae (CREC) representing a particularly problematic species in hospital settings. The COVID-19 pandemic has exacerbated this issue by increasing antibiotic usage and disrupting standard infection control, potentially accelerating the emergence and spread of multidrug-resistant organisms. Despite the critical nature of these trends, comprehensive studies addressing the molecular characteristics, transmission dynamics, and epidemiological features of carbapenemase-encoding genes (CEGs) in CREC during the pandemic period remain limited (Chen et al., 2025).

Key Innovation from the Reference Study

The central innovation of Chen et al. (2025) lies in their systematic molecular and epidemiological characterization of 54 CREC isolates collected contemporaneously from eight tertiary hospitals in Guangdong province. The study uniquely integrates plasmid and chromosomal localization analyses of CEGs with transmission modeling and genotyping, providing a high-resolution view of resistance gene dissemination. Notably, the authors demonstrate that the blaNDM-1 gene predominates among CEGs, with frequent localization on both plasmids and chromosomes, and confirm a remarkably high rate of successful horizontal gene transfer through conjugation experiments (Chen et al., 2025).

Methods and Experimental Design Insights

The investigation analyzed 54 CREC strains collected between December 2022 and June 2024. The following approaches were employed:

• Plasmid Elimination and PCR: Variable temperature SDS plasmid elimination was combined with polymerase chain reaction (PCR) to detect and localize CEGs such as blaNDM-1, blaIMP, and blaKPC-2.
• Antimicrobial Susceptibility Testing: Broth microdilution determined resistance profiles to key antibiotics, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Plasmid Conjugation Experiments: Conjugation assays quantified the horizontal transferability of CEGs.
• Genotyping and Epidemiology: ERIC-PCR combined with NTSYS software characterized genotypic diversity, while clinical metadata enabled stratified epidemiological analysis by age, gender, department, and specimen type (Chen et al., 2025).

Protocol Parameters

• antimicrobial susceptibility assay | broth microdilution; variable concentrations | applicability: Gram-negative multidrug-resistant strains | rationale: Standard for MIC determination and resistance profiling | paper
• CEG detection | PCR (targeting blaNDM-1, blaIMP, blaKPC-2) | clinical and research isolates | rationale: High sensitivity and specificity for gene identification | paper
• plasmid elimination | variable temperature SDS treatment | dissecting plasmid vs. chromosomal CEG carriage | rationale: Differentiates genetic context of resistance | paper
• conjugation assay | filter-mating with recipient strains | modeling horizontal gene transfer | rationale: Direct assessment of transmissibility | paper
• genotyping | ERIC-PCR, NTSYS analysis | epidemiological clustering | rationale: Distinguishes clonal spread vs. polyclonal emergence | paper

Core Findings and Why They Matter

The study uncovered several critical features of CEG-mediated resistance in hospital CREC isolates:

• High Prevalence of CEGs: 85.19% of isolates harbored at least one carbapenemase gene, with blaNDM-1 present in a majority, either solely on plasmids (46.30%) or on both plasmids and chromosomes (33.33%) (Chen et al., 2025).
• Efficient Horizontal Gene Transfer: Conjugation assays demonstrated a 95.65% transfer success rate for CEGs overall, with blaNDM-1 and blaIMP both showing high mobilization efficiency. The blaKPC-2 gene, however, was not transferable under the study conditions.
• Genetic Context and Diversity: Six mobile genetic elements were identified, with ISEcp1 being most prevalent. Many isolates carried multiple element types, suggesting significant potential for gene mobilization.
• Multidrug Resistance Phenotype: CEG-positive strains exhibited significantly elevated resistance to multiple antibiotics, including ciprofloxacin and levofloxacin, compared with CEG-negative controls (source: Chen et al., 2025).
• Epidemiological Patterns: Higher detection rates were observed in male and elderly patients, with respiratory medicine departments and sputum samples yielding the highest proportions of CEG-positive isolates.

The convergence of plasmid- and chromosomal-mediated resistance, combined with efficient horizontal transfer, underscores the urgent need for robust surveillance and research on resistance mechanism dissemination.

Comparison with Existing Internal Articles

Recent thought-leadership and protocol articles have explored ciprofloxacin’s role as a benchmark fluoroquinolone antibiotic for antimicrobial resistance research. These resources consistently emphasize ciprofloxacin’s mechanism as a bacterial DNA gyrase and topoisomerase IV inhibitor, its application in multidrug-resistant Gram-negative models, and its strategic value for experimental workflows:

• Ciprofloxacin at the Frontier of Antimicrobial Resistance... discusses how ciprofloxacin’s mechanism aligns with resistance surveillance in pathogens such as CREC, and provides translational guidance for bridging epidemiological and laboratory findings.
• Ciprofloxacin in Antimicrobial Resistance Research: Proto... offers stepwise protocols and troubleshooting for integrating high-purity ciprofloxacin into susceptibility and mechanism-of-action assays, directly supporting workflows similar to those in the reference study.
• Translational Leverage: Ciprofloxacin as a Strategic Cata... contextualizes recent epidemiological findings from carbapenem-resistant Enterobacter cloacae and links them to experimental design considerations for resistance profiling and antibacterial screening.

These internal resources complement the reference study by providing mechanistic rationale, experimental best practices, and product integration tips for researchers facing similar multidrug resistance and gene transfer challenges.

Limitations and Transferability

Major limitations of the study include the regional focus on Guangdong province, which may limit the generalizability of resistance gene frequencies and epidemiological patterns to other geographic or healthcare contexts. The study’s reliance on hospital-based collection may also underrepresent community-associated CREC strains. Transferability to other Gram-negative species or to non-hospital environments requires further validation (Chen et al., 2025).

Why this cross-domain matters, maturity, and limitations

The integration of epidemiological data with molecular characterization, as modeled in this study, is mature for hospital-acquired Gram-negative pathogens but may not fully extrapolate to other clinical or environmental domains. The study’s methods and findings reinforce the value of combining genetic surveillance with functional assays for a comprehensive view of resistance threats, but molecular mechanisms and transfer rates may differ across bacterial species and settings (source: workflow_recommendation).

Research Support Resources

Researchers aiming to replicate or extend these findings can leverage research-grade Ciprofloxacin (SKU A8399), a synthetic fluoroquinolone antibiotic and validated bacterial DNA topoisomerase inhibitor, for standardized antimicrobial susceptibility testing and resistance mechanism studies. APExBIO provides this compound at high purity, ensuring reproducibility in both clinical and laboratory CREC models (source: product_spec).